Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials

UCLA's Jonsson Comprehensive Cancer Center

UCLA's Jonsson Comprehensive Cancer Center
JCCC: A Comprehensive Cancer Center
JCCC Member Directory
Calendar
Contact Us
Map and Directions to JCCC
Social Media
Connect via Mobile
Privacy Practices
 
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

David Dawson, M.D., Ph.D.
David Dawson, M.D., Ph.D.

Specialty:

Pathology

General Information:

Gender:
Male
Language(s):
English

Affiliation(s):

Assistant Professor, Department of Pathology and Laboratory Medicine
Physician, Department of Pathology and Laboratory Medicine, Surgical Pathology, Gastroenterology/Liver Pathology
Member, JCCC Signal Transduction and Therapeutics Program Area

Hospital Affiliation(s):

Santa Monica - UCLA Medical Center and Orthopaedic Hospital
Ronald Reagan UCLA Medical Center

Education:

Residency:
Anatomic Pathology, UCLA School of Medicine, 2000 - 2001
Internship:
Anatomic and Clinical Pathology, UCLA School of Medicine, 1999 - 2000
Medical Degree:
M.D., Northwestern University Medical School, 1999
Degree:
Ph.D., Northwestern University, 1997

Certification(s):

Medical Board Certification(s):
Anatomic Pathology, American Board of Pathology, 2002

Contact Information:

Surgical Pathology:
(310) 794-9450 Information and referral
Gastroenterology/Liver Pathology:
(310) 794-9450 Information and referral
(310) 267-2680 Referring physician
Email:
ddawson@mednet.ucla.edu

Scientific Interest(s):

Dr. David Dawson is interested in molecular alterations responsible for the development and progression of pancreatic adenocarcinoma. He seeks to define the range of epigenetic modifications that occur in pancreatic cancer and their relationship with altered patterns of gene expression that promote tumor development.

Selected Cancer-Related Publications:

Donahue TR, Tran LM, Hill R, Li Y, Kovochich A, Calvopina JH, Patel SG, Wu N, Hindoyan A, Farrell JJ, Li X, Dawson DW, Wu H. Integrative survival-based molecular profiling of human pancreatic cancer. Clin Cancer Res. 2012 Mar 1;18(5):1352-63. Epub 2012 Jan 18.

White BD, Chien AJ, Dawson DW. Dysregulation of Wnt/Beta-catenin signaling in gastrointestinal cancers. Gastroenterology. 2012 Feb;142(2):219-32. Epub 2011 Dec 8.

Angst E, Dawson DW, Stroka D, Gloor B, Park J, Candinas D, Reber HA, Hines OJ, Eibl G. N-myc downstream regulated gene-1 expression correlates with reduced pancreatic cancer growth and increased apoptosis in vitro and in vivo. Surgery. 2011 May;149(5):614-24. Epub 2011 Jan 14.

Manuyakorn A, Paulus R, Farrell J, Dawson NA, Tze S, Cheung-Lau G, Hines OJ, Reber H, Seligson DB, Horvath S, Kurdistani SK, Guha C, Dawson DW. Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704. J Clin Oncol. 2010 Mar 10;28(8):1358-65. Epub 2010 Feb 8.

Dawson DW, Hong JS, Shen RR, French SW, Troke JJ, Wu YZ, Chen SS, Gui D, Regelson M, Marahrens Y, Morse HC 3rd, Said J, Plass C, Teitell MA. Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas. Oncogene. 2007 Jun 21;26(29):4243-52. Epub 2007 Jan 29.

In the News: